Opinion|Videos|December 3, 2024
Addressing Challenges in Accessing Traditional STI Screening Options
Author(s)Kameelah Phillips, MD, FACOG, NCMP
The panelist discusses how asymptomatic sexually transmitted infections (STIs) can silently impact overall health, emphasizing the importance of comprehensive screening and education, particularly for less known STIs like trichomoniasis and Mycoplasma genitalium, while exploring how newer testing methods like nucleic acid amplification testing (NAAT) can address challenges in traditional screening access and improve patient care.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- In what ways can asymptomatic STIs impact overall health, and why is screening important?
- How can health care providers effectively raise awareness about less commonly known STIs like trichomoniasis and Mycoplasma genitalium?
- What challenges do patients face when accessing traditional STI screenings testing, and how can these be addressed?
- How does the use of newer screening methods like NAAT impact patient access to necessary screenings?
Advertisement
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
HIV screening, PrEP counseling get stronger ACOG recommendation
2
Biomarker testing for preeclampsia with Lisa A. Bukovac, DO, FACOG
3
GLP-1 RAs linked to broad menstrual adverse event signals in reproductive-aged patients
4
Closing the STI screening and follow-up gap in pregnancy, with Damian Alagia, III, MD
5